Genetic Future

Archives for January, 2010

Blogging hiatus

Blogging on Genetic Future will be pretty much non-existent for the next three weeks.

Disclaimer: my wife and I have both received and used free testing kits from Counsyl. Counsyl is a rather enigmatic player in the personal genomics field: apart from a brief mention in Steven Pinker’s excellent NY Times piece over a year ago and an even briefer post on a Newsweek blog late last year, the…

Weekly Twitter summary

Continuing my new tradition, here are some of the genomics-related links and information I posted on Twitter this week:

Keith Robison has a perceptive piece riffing off the recent Illumina instrument launch, and ponders whether 2010 will be the year that array-based genomic technologies finally start to die off with the rise of sequencing. The market certainly seems to think so. Check out the immediate effect on stock prices for Illumina (ILMN) and array…

The big news from the JP Morgan investment conference today is the announcement of a brand new shiny sequencing machine from Illumina, the HiSeq 2000. The new machine boasts an impressive set of statistics, and looks likely to gradually replace Illumina’s GAIIx as the workhorse of most modern sequencing facilities. So, how excited should we…

Weekly Twitter summary

Some of you may know that I post many links of interest that don’t make it into a full blog post via Twitter. Since I know there are a number of blog readers who haven’t yet made the move to Twitter, I’m going to follow in Dan Vorhaus’ footsteps by posting a weekly roundup of…

Personal genomics links of note

Several articles with a personal genomics theme popped up today. Most importantly, this piece in the Times by Mark Henderson is a superb analysis of the current state and likely future of the personal genomics industry, and a must-read for anyone interested in the field. Henderson notes that despite the turmoil in the industry in…

Genetic genealogist Blaine Bettinger has a fantastic post dissecting and contextualising a rather worrying result from his personal genomic analysis: a 50-60% increased lifetime risk of type 2 diabetes. Blaine is unfortunate enough to be among the 1-2% of individuals who carry two risky versions at each of three major risk variants for the disease.…

The Gene Sherpa predicts that Complete Genomics will win the Archon X Prize in Genomics in 2010. In the comments, Keith Robison is wisely skeptical. I agree with Keith – it’s unlikely that the X Prize will be won this year, and if it is the winner is unlikely to be Complete Genomics. For those…